Cerephex, based in Los Gatos, CA and Ann Arbor, MI, is a privately held medical device company focused on developing therapies and diagnostic technologies that address centralization in chronic pain conditions. Cerephex is conducting clinical trials of their NeuroPoint® product, a point-of-care device built on their patented Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE®) signal technology platform.

For more information visit: http://www.cerephex.com/